Glutamate transporters play a crucial role in physiological glutamate homeostasis and neurotoxicity. Recently, we have shown that downregulation of glutamate transporters after chronic morphine exposure contributed to the development of morphine tolerance. In the present study, we examined whether regulation of the glutamate transporter expression with the proposed proteasome inhibitor MG-132 would contribute to the development of tolerance to repeated intrathecal (twice daily Â 7 days) morphine administration in rats. The results showed that MG-132 (5 nmol) given intrathecally blocked morphine-induced glutamate transporter downregulation and the decrease in glutamate uptake activity within the spinal cord dorsal horn. Co-administration of morphine (15 nmol) with MG-132 (vehicle = 1 < 2.5 < 5 = 10 nmol) also dose-dependently prevented the development of morphine tolerance in rats. These findings suggest that prevention of spinal glutamate transporter downregulation may regulate the glutamatergic function that has been implicated in the development of morphine tolerance. The possible relationship between MG-132-mediated regulation of glutamate transporters, ubiquitin-proteasome system, and the cellular mechanisms of morphine tolerance is discussed in light of these findings. Ó
Introduction
Glutamate transporters play a crucial role in physiological glutamate homeostasis, neurotoxicity, and glutamatergic regulation of opioid tolerance [12, 15, 16, 26, 28] . However, how the glutamate transport degradation is regulated remains unclear. The ubiquitin-proteasome system (UPS) is a major non-lysosomal proteolytic pathway that degrades cellular proteins including those with important roles in the regulation of cell growth and function [4, 7, 21] . In addition, activation of UPS has been shown to regulate the PSD-95 degradation and AMPA receptor surface expression [3] , suggesting a possible relationship between UPS and glutamatergic activities.
Ubiquitination is a process involving three enzymes: E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase) [8, 29] . Interactions between an E3 ligase and its target molecule are considered a key step in determining the selectivity of UPS for a target molecule and its subsequent proteasomal degradation, a process that is subject to intracellular modulation by various upstream regulators [29] . Antinociceptive tolerance induced by chronic morphine has been shown to be mediated, at least in part, through a central glutamatergic mechanism including an altered glutamate transporter expression [14, 15, 23, 25, 27] . Inhibition of glutamate transporter activity directly contributes to a heightened activity of N-methyl-D-aspartate receptors (NMDAR) and the development of opioid tolerance [24] . These previous studies suggest that the regulation of the glutamate transporter turnover may contribute to the mechanisms of opioid tolerance. 
